Cargando…

Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease

Demyelination underlies early neurological symptoms in multiple sclerosis (MS); however, axonal damage is considered critical for permanent chronic deficits. The precise mechanisms by which axonal injury occurs in MS are unclear; one hypothesis is the absence or failure of remyelination, suggesting...

Descripción completa

Detalles Bibliográficos
Autores principales: Wootla, Bharath, Denic, Aleksandar, Watzlawik, Jens O., Warrington, Arthur E., Rodriguez, Moses
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012151/
https://www.ncbi.nlm.nih.gov/pubmed/26409478
http://dx.doi.org/10.1007/s12035-015-9436-3
_version_ 1782451964161818624
author Wootla, Bharath
Denic, Aleksandar
Watzlawik, Jens O.
Warrington, Arthur E.
Rodriguez, Moses
author_facet Wootla, Bharath
Denic, Aleksandar
Watzlawik, Jens O.
Warrington, Arthur E.
Rodriguez, Moses
author_sort Wootla, Bharath
collection PubMed
description Demyelination underlies early neurological symptoms in multiple sclerosis (MS); however, axonal damage is considered critical for permanent chronic deficits. The precise mechanisms by which axonal injury occurs in MS are unclear; one hypothesis is the absence or failure of remyelination, suggesting that promoting remyelination may protect axons from death. This report provides direct evidence that promoting oligodendrocyte remyelination protects axons and maintains transport function. Persistent Theiler’s virus infection of Swiss Jim Lambert (SJL)/J mice was used as a model of MS to assess the effects of remyelination on axonal injury following demyelination in the spinal cord. Remyelination was induced using an oligodendrocyte/myelin-specific recombinant human monoclonal IgM, rHIgM22. The antibody is endowed with strong anti-apoptotic and pro-proliferative effects on oligodendrocyte progenitor cells. We used (1)H-magnetic resonance spectroscopy (MRS) at the brainstem to measure N-acetyl-aspartate (NAA) as a surrogate of neuronal health and spinal cord integrity. We found increased brainstem NAA concentrations at 5 weeks post-treatment with rHIgM22, which remained stable out to 10 weeks. Detailed spinal cord morphology studies revealed enhanced remyelination in the rHIgM22-treated group but not in the isotype control antibody- or saline-treated groups. Importantly, we found rHIgM22-mediated remyelination protected small- and medium-caliber mid-thoracic spinal cord axons from damage despite similar demyelination and inflammation across all experimental groups. The most direct confirmation of remyelination-mediated protection of descending neurons was an improvement in retrograde transport. Treatment with rHIgM22 significantly increased the number of retrograde-labeled neurons in the brainstem, indicating that preserved axons are functionally competent. This is direct validation that remyelination preserves spinal cord axons and protects functional axon integrity.
format Online
Article
Text
id pubmed-5012151
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-50121512016-09-19 Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease Wootla, Bharath Denic, Aleksandar Watzlawik, Jens O. Warrington, Arthur E. Rodriguez, Moses Mol Neurobiol Article Demyelination underlies early neurological symptoms in multiple sclerosis (MS); however, axonal damage is considered critical for permanent chronic deficits. The precise mechanisms by which axonal injury occurs in MS are unclear; one hypothesis is the absence or failure of remyelination, suggesting that promoting remyelination may protect axons from death. This report provides direct evidence that promoting oligodendrocyte remyelination protects axons and maintains transport function. Persistent Theiler’s virus infection of Swiss Jim Lambert (SJL)/J mice was used as a model of MS to assess the effects of remyelination on axonal injury following demyelination in the spinal cord. Remyelination was induced using an oligodendrocyte/myelin-specific recombinant human monoclonal IgM, rHIgM22. The antibody is endowed with strong anti-apoptotic and pro-proliferative effects on oligodendrocyte progenitor cells. We used (1)H-magnetic resonance spectroscopy (MRS) at the brainstem to measure N-acetyl-aspartate (NAA) as a surrogate of neuronal health and spinal cord integrity. We found increased brainstem NAA concentrations at 5 weeks post-treatment with rHIgM22, which remained stable out to 10 weeks. Detailed spinal cord morphology studies revealed enhanced remyelination in the rHIgM22-treated group but not in the isotype control antibody- or saline-treated groups. Importantly, we found rHIgM22-mediated remyelination protected small- and medium-caliber mid-thoracic spinal cord axons from damage despite similar demyelination and inflammation across all experimental groups. The most direct confirmation of remyelination-mediated protection of descending neurons was an improvement in retrograde transport. Treatment with rHIgM22 significantly increased the number of retrograde-labeled neurons in the brainstem, indicating that preserved axons are functionally competent. This is direct validation that remyelination preserves spinal cord axons and protects functional axon integrity. Springer US 2015-09-26 2016 /pmc/articles/PMC5012151/ /pubmed/26409478 http://dx.doi.org/10.1007/s12035-015-9436-3 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Wootla, Bharath
Denic, Aleksandar
Watzlawik, Jens O.
Warrington, Arthur E.
Rodriguez, Moses
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
title Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
title_full Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
title_fullStr Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
title_full_unstemmed Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
title_short Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
title_sort antibody-mediated oligodendrocyte remyelination promotes axon health in progressive demyelinating disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012151/
https://www.ncbi.nlm.nih.gov/pubmed/26409478
http://dx.doi.org/10.1007/s12035-015-9436-3
work_keys_str_mv AT wootlabharath antibodymediatedoligodendrocyteremyelinationpromotesaxonhealthinprogressivedemyelinatingdisease
AT denicaleksandar antibodymediatedoligodendrocyteremyelinationpromotesaxonhealthinprogressivedemyelinatingdisease
AT watzlawikjenso antibodymediatedoligodendrocyteremyelinationpromotesaxonhealthinprogressivedemyelinatingdisease
AT warringtonarthure antibodymediatedoligodendrocyteremyelinationpromotesaxonhealthinprogressivedemyelinatingdisease
AT rodriguezmoses antibodymediatedoligodendrocyteremyelinationpromotesaxonhealthinprogressivedemyelinatingdisease